FindTrial
Sign In

Cinical study of Qinggan Jiangzhi Decoction Combined with external therapy of traditional Chinese medicine in the treatment of metabolic fatty liver disease

Cinical study of Qinggan Jiangzhi Decoction Combined with external therapy of traditional Chinese medicine in the treatment of metabolic fatty liver disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037994
Enrollment
Unknown
Registered
2020-09-08
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatty liver disease

Interventions

TCM external treatment group:Acupoint application of Qinggan Jiangzhi Decoction in TCM external treatment group

Sponsors

Shanghai Hospital of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The patients who meet the diagnostic criteria of Western medicine, and the syndrome of spleen deficiency, phlegm and blood stasis is in accordance with the syndrome differentiation of traditional Chinese medicine; 2. Patients who are willing to cooperate with this study protocol should sign informed consent, aged 18-70 years.

Exclusion criteria

Exclusion criteria: 1. Patients who fail to take medicine and observe according to regulations, 2. Patients who discontinue treatment due to non drug factors, 3. Patients who cannot judge the curative effect, 4. Patients with incomplete data affecting the efficacy and safety judgment.

Design outcomes

Primary

MeasureTime frame
Alanine aminotransferase;—

Countries

China

Contacts

Public ContactYu Sheng

Shanghai Hospital of Traditional Chinese Medicine

1069@szy.sh.cn+86 13611708306

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026